The design and the synthesis of new self-assembling conjugates is reported. The target compounds are characterized by the presence of a self-immolative linker that secures a controlled release induced by lipase cleavage. 4-(1,2-Diphenylbut-1-en-1-yl)aniline is used as a self-assembling inducer and aminothiocolchicine as prototype of drug. The release of thiocolchicine derivative has been demonstrated in vitro in the presence of porcine pancreatic lipase and Celite-supported lipase. The formation of nanoparticles is confirmed by dynamic light scattering, atomic force microscopy, and fluorescence microscopy. The antiproliferative activity has been proved on two human cancer cell lines.
Self-assembling Releasable Thiocolchicine–Diphenylbutenylaniline Conjugates / G. Fumagalli, L. Polito, E. Colombo, F. Foschi, M.S. Christodoulou, F. Galeotti, D. Perdicchia, I. Bassanini, S. Riva, P. Seneci, A. García-Argáez, L. Dalla Via, D. Passarella. - In: ACS MEDICINAL CHEMISTRY LETTERS. - ISSN 1948-5875. - (2019 Jan 04). [Epub ahead of print] [10.1021/acsmedchemlett.8b00605]
Self-assembling Releasable Thiocolchicine–Diphenylbutenylaniline Conjugates
G. FumagalliPrimo
;L. PolitoSecondo
;E. Colombo;F. Foschi;M.S. Christodoulou;D. Perdicchia;I. Bassanini;S. Riva;P. Seneci;D. PassarellaUltimo
2019
Abstract
The design and the synthesis of new self-assembling conjugates is reported. The target compounds are characterized by the presence of a self-immolative linker that secures a controlled release induced by lipase cleavage. 4-(1,2-Diphenylbut-1-en-1-yl)aniline is used as a self-assembling inducer and aminothiocolchicine as prototype of drug. The release of thiocolchicine derivative has been demonstrated in vitro in the presence of porcine pancreatic lipase and Celite-supported lipase. The formation of nanoparticles is confirmed by dynamic light scattering, atomic force microscopy, and fluorescence microscopy. The antiproliferative activity has been proved on two human cancer cell lines.File | Dimensione | Formato | |
---|---|---|---|
acsmedchemlett.8b00605.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.44 MB
Formato
Adobe PDF
|
1.44 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.